How to Love your Job: Surprising Inspiration from a Disney Short Film

How to Love your Job: Surprising Inspiration from a Disney Short Film

I had one of those “I love my job” moments the other day at a cardio class. Not as an instructor, but as a consultant (and class member). I was there to observe the experience of the class for a customer engagement project and to interview some participants afterwards. It was the first moment I realized, while doing my high knees and grapevine, that this was my job.…

Read More
The Role of the PMO in M&A Transitions

The Role of the PMO in M&A Transitions

In a previous post, I outlined key considerations merging companies should consider when preparing for a successful Day 1. One of the most important aspects of readiness planning is establishing a Project Management Office (PMO).  All teams contributing to the transition should report to the PMO. In this post, I’ll discuss the PMO’s role in Day 1 readiness.…

Read More
CES, Augmentation, and What it Means for Customer Experience – Our Visit to CES 2017

CES, Augmentation, and What it Means for Customer Experience – Our Visit to CES 2017

Ah, CES – the only Consumer Electronics Show that matters (i.e., the most media coverage). Our visit to CES began with a simple inquisitive question of not only what’s the next thing that will be integrated into our daily usage patterns. Spurred by our burning curiosity, we resolved to arrive at CES on the closing weekend, only to be met with lights and displays of such ferocity that it begs...

Read More
Unity and Inclusion LA Sparks Dialogue on Diversity in Tech

Unity and Inclusion LA Sparks Dialogue on Diversity in Tech

This weekend, I had the opportunity to participate in the 2017 Unity and Inclusion LA event hosted by 500 Start-Ups; a special one-day event that brought together entrepreneurs, investors and the greater tech community to hold a dialogue about the future of diversity & inclusion in tech. While we did not don the signature pink knit hats, no one failed to recognize the significance of...

Read More
What The Presidential Transition Can Teach Us About Mergers

What The Presidential Transition Can Teach Us About Mergers

Any transition can be difficult, be it a transition from a Democrat President to Republican President, or a merger transition that results from the acquisition of one firm by another, and subsequent integration.  In both cases, readiness planning is key to a successful start.  Significant work must be done early in the transition period to ensure that the Day 1 (i.e.…

Read More
ERP Project Scenarios You May Find Yourself in…and How to Avoid Them

ERP Project Scenarios You May Find Yourself in…and How to Avoid Them

An Enterprise Resource Planning (ERP) solution is the nervous system of a business. ERP systems enable companies to improve efficiency and make smarter operational decisions. ERP projects can be transformational, long, and impact many functional areas of the business. These projects can be wildly successful, but too often they miss deadlines, go over budget, and cause many sleepless and...

Read More
Microsoft MVP Q&A with Jason Farrell

Microsoft MVP Q&A with Jason Farrell

Our very own Jason Farrell,  principal in our Technology practice, was recently named a Microsoft MVP in “Visual Studio and Development Tools”, specifically for his expertise in Xamarin and and his contributions to the tech community. MVP is difficult to attain and a highly prestigious award.  Jason’s recognition comes with a fair amount of hard work – for example MVPs must be...

Read More
How to Capture Market Share Through Data-Driven Drug Discovery

How to Capture Market Share Through Data-Driven Drug Discovery

For years pharmaceutical companies have taken existing drugs and repurposed or repositioned them to create new drugs. These new drugs are often geared towards neglected therapeutic areas. Drug repurposing has always been a solid “go to” strategy and a proven method for mitigating the financial risk of drug discovery and a means of addressing softening market share.…

Read More
In the “Buy vs. Build” world of Pharma, Does Lab Productivity Still Matter?

In the “Buy vs. Build” world of Pharma, Does Lab Productivity Still Matter?

The cost of developing new drugs averages about $500,000 a day over 12 to 14 years (~$2.5B average cost per new drug). This high development spend has not translated into a meaningful number of additional new medical entities approved by the FDA (about ~35 per year). High development costs and thin pipelines have led many companies to shift towards a strategy of acquiring new drugs by...

Read More
Phone: 312-602-4000
Email: marketing@westmonroepartners.com
222 W. Adams
Chicago, IL 60606
Show Buttons
Share On Facebook
Share On Twitter
Share on LinkedIn
Hide Buttons